日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real‐world analysis from 20 US centers

纳武利尤单抗联合AVD方案作为经典型霍奇金淋巴瘤患者的一线治疗:来自美国20个中心的真实世界分析

Quinquenel, Anne; Aurran-Schleinitz, Thérèse; Clavert, Aline; Cymbalista, Florence; Dartigeas, Caroline; Davi, Frédéric; de Guibert, Sophie; Delmer, Alain; Dilhuydy, Marie-Sarah; Feugier, Pierre; Fornecker, Luc-Matthieu; Ghez, David; Guieze, Romain; Laribi, Kamel; Leblond, Véronique; Leprêtre, Stéphane; Letestu, Rémi; Lévy, Vincent; Nguyen-Khac, Florence; Michallet, Anne-Sophie; Tomowiak, Cécile; Tournilhac, Olivier; Ysebaert, Loïc; Troussard, Xavier; Bock, Allison M; Hao, Peirong; Xu, Yizhe; Luttwak, Efrat; Thiruvengadam, Swetha Kambhampati; Sekaran, Kanithra; Sano, Dahlia; Vaughn, John; Sharp, John; Major, Ajay; Patel, Vrutti; Smilnak, Gordon; Araujo, Nicole; Mynam, Ritwick; Reef, Daniel; Palmeri, Marisa; Gerber, Drew; Abhyankar, Anuja; Baek, Grace; Falade, Ayo; Iqbal, Madiha; Hu, Boyu; Geethakumari, Praveen Ramakrishnan; Durani, Urshila; Di, Mengyang; Niu, Alex; Cherng, Hua‐Jay J; Rhodes, Joanna M; Grover, Natalie; Pophali, Priyanka; Feldman, Tatyana; Shanmugasundaram, Krithika; Svoboda, Jakub; Voorhees, Timothy; Diefenbach, Catherine; Karimi, Yasmin; Karmali, Reem; Herrera, Alex F; Torka, Pallawi; Epperla, Narendranath

Measurable residual disease-guided combination of ibrutinib plus venetoclax versus FCR in previously untreated patients with intermediate-risk chronic lymphocytic leukaemia: a phase 2, randomised trial (ERADIC) from the FILO group

在既往未接受治疗的中危慢性淋巴细胞白血病患者中,以可测量的残余病灶为指导,比较伊布替尼联合维奈克拉与FCR方案的疗效:一项来自FILO组的II期随机试验(ERADIC)。

Quinquenel, Anne; Letestu, Rémi; Le Garff-Tavernier, Magali; Morisset, Stéphane; Subtil, Fabien; Aurran, Thérèse; Laribi, Kamel; Cymbalista, Florence; Lévy, Vincent; Simon, Laurence; Roos-Weil, Damien; Leblond, Véronique; Dilhuydy, Marie-Sarah; Tomowiak, Cécile; Dartigeas, Caroline; Guièze, Romain; Tournilhac, Olivier; Ferrant, Emmanuelle; de Guibert, Sophie; Feugier, Pierre; Merabet, Fatiha; Leprêtre, Stéphane; Carassou, Philippe; Gay, Julie; Hivert, Bénédicte; Fornecker, Luc-Matthieu; Dupuis, Jehan; Molina, Lysiane; Villemagne, Bruno; Cartron, Guillaume; Drenou, Bernard; Mahé, Beatrice; Benbrahim, Omar; Cahu, Xavier; Portois, Christelle; Ysebaert, Loïc; Nguyen-Khac, Florence; Dahmani, Abdelmalek; Quiney, Claire; Rouillé, Valérie; Delmer, Alain; Michallet, Anne-Sophie

Anti-HLA class I IgG subclasses skew platelet activation mechanisms in transfusion refractoriness

抗HLA I类IgG亚类在输血无效中影响血小板活化机制

Couvidou, Adèle; Wald, Mathieu; Angénieux, Catherine; Pires-Marafon, Juliana; Apithy, Marie-Joëlle; Humbrecht, Catherine; Fornecker, Luc-Matthieu; Congy-Jolivet, Nicolas; Dupuis, Arnaud; Rollin, Jérôme; Maître, Blandine

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials

来自LYSA研究组的混合临床试验和真实世界数据的合成对照组,适用于80岁以上未经治疗的弥漫性大B细胞淋巴瘤患者:一项切实可行的创新临床试验策略

Letailleur, Valentin; Chaillol, Isabelle; Cherblanc, Fanny; Ghesquières, Hervé; Peyrade, Frédéric; Guidez, Stéphanie; Bijou, Fontanet; Sesques, Pierre; Rossi, Cédric; Fornecker, Luc-Matthieu; Fouillet, Ludovic; Carras, Sylvain; Chartier, Loïc; Belot, Aurélien; Oberic, Lucie; Jardin, Fabrice; Tessoulin, Benoit

Clinical benefit of tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma: real-world data from the EarlyMIND study

tafasitamab联合来那度胺治疗复发或难治性弥漫性大B细胞淋巴瘤的临床获益:来自EarlyMIND研究的真实世界数据

Brisou, Gabriel; Paillassa, Jérôme; Bernard, Sophie; Tournilhac, Olivier; Fornecker, Luc-Matthieu; Maloisel, Frédéric; Gastaud, Lauris; Durot, Eric; Tempescul, Adrian; Braun, Thorsten; Ivanov, Vadim; Cherel, Brieuc; Serrier, Caroline; Delage, Jeremy; El Yamani, Abderrazak; Delapierre, Baptiste; Lebras, Laure; Lestang, Elsa; Villesuzanne, Camille; Agape, Philippe; Escure, Guillaume; Fouillet, Ludovic; Nicol, Christophe; Olivier, Gaëlle; Levy, Anthony; Le Bris, Anne-Sophie; Cassuto, Ophélie; Jacquemelle, Laura; Haioun, Corinne; Herbaux, Charles

Atezolizumab, obinutuzumab and venetoclax for the treatment of patients with relapsed/refractory B non-Hodgkin lymphoma: Final analysis of a phase II trial from the LYSA group

阿特珠单抗、奥妥珠单抗和维奈托克治疗复发/难治性B细胞非霍奇金淋巴瘤患者:LYSA研究组II期试验的最终分析

Herbaux, Charles; Bachy, Emmanuel; Bouabdallah, Reda; Guidez, Stéphanie; Casasnovas, Olivier; Feugier, Pierre; Damaj, Gandhi; Tilly, Hervé; Ysebaert, Loïc; Le Gouill, Steven; Morineau, Nadine; Gyan, Emmanuel; Gressin, Rémy; Houot, Roch; Cheminant, Morgane; Morschhauser, Franck; Thieblemont, Catherine; Haioun, Corinne; Nicolas-Virelizier, Emmanuelle; Fornecker, Luc-Matthieu; Daguindau, Nicolas; Cartron, Guillaume

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

通过非侵入性基因组分析定义的霍奇金淋巴瘤不同亚型

Stefan K Alig # ,Mohammad Shahrokh Esfahani # ,Andrea Garofalo # ,Michael Yu Li # ,Cédric Rossi ,Tim Flerlage ,Jamie E Flerlage ,Ragini Adams ,Michael S Binkley ,Navika Shukla ,Michael C Jin ,Mari Olsen ,Adèle Telenius ,Jurik A Mutter ,Joseph G Schroers-Martin ,Brian J Sworder ,Shinya Rai ,Daniel A King ,Andre Schultz ,Jan Bögeholz ,Shengqin Su ,Karan R Kathuria ,Chih Long Liu ,Xiaoman Kang ,Maya J Strohband ,Deanna Langfitt ,Kristine Faye Pobre-Piza ,Sherri Surman ,Feng Tian ,Valeria Spina ,Thomas Tousseyn ,Lieselot Buedts ,Richard Hoppe ,Yasodha Natkunam ,Luc-Matthieu Fornecker ,Sharon M Castellino ,Ranjana Advani ,Davide Rossi ,Ryan Lynch ,Hervé Ghesquières ,Olivier Casasnovas ,David M Kurtz ,Lianna J Marks ,Michael P Link ,Marc André ,Peter Vandenberghe ,Christian Steidl ,Maximilian Diehn ,Ash A Alizadeh

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling

通过非侵入性基因组分析定义的霍奇金淋巴瘤不同亚型

Stefan K Alig #,Mohammad Shahrokh Esfahani #,Andrea Garofalo #,Michael Yu Li #,Cédric Rossi,Tim Flerlage,Jamie E Flerlage,Ragini Adams,Michael S Binkley,Navika Shukla,Michael C Jin,Mari Olsen,Adèle Telenius,Jurik A Mutter,Joseph G Schroers-Martin,Brian J Sworder,Shinya Rai,Daniel A King,Andre Schultz,Jan Bögeholz,Shengqin Su,Karan R Kathuria,Chih Long Liu,Xiaoman Kang,Maya J Strohband,Deanna Langfitt,Kristine Faye Pobre-Piza,Sherri Surman,Feng Tian,Valeria Spina,Thomas Tousseyn,Lieselot Buedts,Richard Hoppe,Yasodha Natkunam,Luc-Matthieu Fornecker,Sharon M Castellino,Ranjana Advani,Davide Rossi ,Ryan Lynch,Hervé Ghesquières,Olivier Casasnovas,David M Kurtz,Lianna J Marks,Michael P Link,Marc André,Peter Vandenberghe,Christian Steidl,Maximilian Diehn,Ash A Alizadeh

Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial

Blinatumomab 在 R-CHOP 桥接治疗后用于 Richter 转化患者:一项 II 期多中心试验

Guièze, Romain; Ysebaert, Loïc; Roos-Weil, Damien; Fornecker, Luc-Mathieu; Ferrant, Emmanuelle; Molina, Lysiane; Aurran, Thérèse; Clavert, Aline; de Guibert, Sophie; Michallet, Anne-Sophie; Saad, Alain; Drénou, Bernard; Quittet, Philippe; Hivert, Bénédicte; Laribi, Kamel; Gay, Julie; Quinquenel, Anne; Broseus, Julien; Rouille, Valérie; Schwartz, David; Magnin, Benoit; Lazarian, Grégory; Véronèse, Lauren; de Antonio, Marie; Laurent, Camille; Tournilhac, Olivier; Pereira, Bruno; Feugier, Pierre

Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group

RiBVD II期试验的长期分析揭示了TP53突变和低白蛋白血症对老年套细胞淋巴瘤患者的不利影响;对于LYSA组

Carras, Sylvain; Torroja, Alexia; Emadali, Anouk; Montaut, Emilie; Daguindau, Nicolas; Tempescul, Adrian; Moreau, Anne; Tchernonog, Emmanuelle; Schmitt, Anna; Houot, Roch; Dartigeas, Caroline; Barbieux, Sarah; Corm, Selim; Banos, Anne; Fouillet, Ludovic; Dupuis, Jehan; Macro, Margaret; Fleury, Joel; Jardin, Fabrice; Sarkozy, Clementine; Damaj, Ghandi; Feugier, Pierre; Fornecker, Luc Matthieu; Chabrot, Cecile; Dorvaux, Veronique; Bouabdallah, Krimo; Amorim, Sandy; Garidi, Reda; Voillat, Laurent; Joly, Bertrand; Morineau, Nadine; Moles, Marie Pierre; Zerazhi, Hacene; Fontan, Jean; Arkam, Yazid; Alexis, Magda; Delwail, Vincent; Vilque, Jean Pierre; Ysebaert, Loic; Burroni, Barbara; Callanan, Mary; Le Gouill, Steven; Gressin, Rémy